This information was published on 2026-04-08T00:06:41 for IP Right Acceptance Published.
| Field | Value |
| (210) | 2613376 (IR 1892892) |
| (220) |
07 Nov 2025
|
| (500) |
The mark consists of the stylized word "tyrvaya" with stacked arches extending from the first "y" to the second "y" in the word; the TYR in "tyrvaya" is depicted in purple and VAYA is depicted in green; each arch is composed of six dots, each dot increasing in size from left to right, with the dot on the far right shaped as a droplet; the first arch of dots is purple, the second arch is blue and the third arch is green.
The color(s) Purple, blue and green is/are claimed as a feature of the mark. The mark consists of the stylized word "tyrvaya" with stacked arches extending from the first "y" to the second "y" in the word; the TYR in "tyrvaya" is depicted in purple and VAYA is depicted in green; each arch is composed of six dots, each dot increasing in size from left to right, with the dot on the far right shaped as a droplet; the first arch of dots is purple, the second arch is blue and the third arch is green. |
| (511) (510) |
Class 5
Pharmaceutical preparations for the treatment of dry eye disease; pharmaceutical preparations for the treatment of neurotropic keratitis; pharmaceutical preparations for the treatment of ophthalmological diseases; nasal spray preparations; pharmaceutical preparations in the form of nasal sprays for the treatment of ophthalmological diseases. |
| (540) |
|
| (550) | Figurative |
| (730) |
Oyster Point Pharma, Inc.
|
Find out more about publications on the About page.